Bausch + Lomb BLCO Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total revenues by Business | |||||
| Pharmaceuticals | $1.08B+11.6% | $969M+56.8% | $618M+32.1% | $468M-5.1% | |
| Surgical | $894M+6.0% | $843M+9.9% | $767M+6.8% | $718M0.0% | |
| Vision Care | $2.92B+6.7% | $2.74B+7.7% | $2.54B+7.3% | $2.37B+1.8% | |
| Total revenues by Product | |||||
| Branded and Other Generics | $242M-13.9% | $281M+11.5% | $252M+2.9% | $245M-3.5% | |
| Devices | $1.92B+6.8% | $1.8B+9.1% | $1.65B+5.0% | $1.57B-1.5% | |
| OTC | $1.84B+6.4% | $1.72B+7.0% | $1.61B+10.3% | $1.46B+4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch + Lomb break its business down?
- Bausch + Lomb (BLCO) reports total revenues by business across 3 parts — Pharmaceuticals, Surgical and Vision Care. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch + Lomb's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch + Lomb's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.